One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients
Crossref DOI link: https://doi.org/10.1007/s12020-016-0951-4
Published Online: 2016-04-13
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Boschetti, Mara
Agosti, Sergio
Albanese, Valeria
Casalino, Laura
Teti, Claudia
Bezante, Gian Paolo
Brunelli, Claudio
Albertelli, Manuela
Ferone, Diego
Text and Data Mining valid from 2016-04-13